Following the release of her album ‘The Life of a Showgirl’, Taylor continues to demonstrate that intellectual property (IP) is not just a legal asset, it’s a keystone of brand power and control… read more…
In the rapidly evolving world of cosmetics, biotherapeutic molecules, which were once confined to medical and pharmaceutical settings, are now making their way into skincare products, reshaping the… read more…
On the 15th of July 2025, the UK Government released a consultation on SEPs (Standard Essential Patents) With the aim of facilitating innovation for UK businesses in the digital technology industry,… read more…
Mathys & Squire is delighted that Partners Sean Leach, Anna Gregson, Dani Kramer and Martin MacLean have all been identified in the 2025 edition of IAM Strategy 300: The World’s Leading IP… read more…
Ultra-processed foods (UPFs) are firmly integrated within modern diets, with factors such as convenience, store availability, cost, food waste and time impacting consumer purchase decisions However,… read more…
Investment Surges in AI-Driven Drug Discovery Artificial intelligence (AI) has emerged as one of the most transformative technologies in recent years The European Medtech sector saw a surge in… read more…
Over the past four weeks, we have been joined by students Mubarak Ahmed, Ejiro Williams and Mahfuz Ahmed in our London Office, the Shard, through our partnership with Career Ready Throughout… read more…
Mathys & Squire have published a report on the use of the Unitary Patent system in the field of IT & engineering, sharing the results of a survey on the patents granted to a selected number… read more…
Partners Hazel Ford and Alexander Robinson have been featured in the Life Sciences IP Review (LSIPR) providing insights on the latest developments impacting the European Patent Office Boards of… read more…